Compare SLB & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLB | COR |
|---|---|---|
| Founded | 1926 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Other Pharmaceuticals |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 77.4B | 68.5B |
| IPO Year | 1996 | 2001 |
| Metric | SLB | COR |
|---|---|---|
| Price | $52.65 | $322.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 20 | 13 |
| Target Price | $52.25 | ★ $390.62 |
| AVG Volume (30 Days) | ★ 17.4M | 1.4M |
| Earning Date | 04-24-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.27% | 0.74% |
| EPS Growth | N/A | ★ 5.71 |
| EPS | 2.35 | ★ 2.87 |
| Revenue | $30,440,000,000.00 | ★ $321,332,819,000.00 |
| Revenue This Year | $4.49 | $8.91 |
| Revenue Next Year | $5.78 | $6.84 |
| P/E Ratio | ★ $22.11 | $113.10 |
| Revenue Growth | ★ 9.46 | 9.31 |
| 52 Week Low | $31.64 | $273.43 |
| 52 Week High | $54.80 | $377.54 |
| Indicator | SLB | COR |
|---|---|---|
| Relative Strength Index (RSI) | 61.31 | 42.72 |
| Support Level | $48.07 | $287.38 |
| Resistance Level | $54.80 | $353.18 |
| Average True Range (ATR) | 2.01 | 7.89 |
| MACD | 0.24 | 1.22 |
| Stochastic Oscillator | 75.65 | 61.27 |
SLB is the world's premier oilfield-services company as measured by market share. While the industry is largely fragmented, SLB holds the first or second competitive position in many of the differentiated oligopolies in which it operates. Also known as Schlumberger, the company was founded in 1926 by two brothers bearing the same last name. Today, it's most known as a global industry leader in innovation, while it focuses its strategy on its three growth engines: core, digital, and new energy businesses. Over three-fourths of its revenue base is tied to international markets, while the company boasts nearly $3 billion in digital-related revenue.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.